Clinical Trials
6
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Long-term Safety and Performance of the ARGOS-SC Suprachoroidal Pressure Sensor System in Patients With Glaucoma Underwent Non-penetrating Glaucoma Surgery
- Conditions
- GlaucomaOpen Angle Glaucoma
- First Posted Date
- 2021-02-26
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Implandata Ophthalmic Products GmbH
- Target Recruit Count
- 22
- Registration Number
- NCT04773106
- Locations
- 🇩🇪
Universitäts-Augenklinik Bochum, Bochum, Germany
🇩🇪Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Augenklinik und Poliklinik, Mainz, Germany
🇩🇪Augenklinik der LMU München, München, Germany
Performance and Safety of the ARGOS-SC Suprachoroidal Pressure Sensor in Patients With Glaucoma Undergoing Non-penetrating Glaucoma Surgery
- Conditions
- GlaucomaOpen Angle Glaucoma
- First Posted Date
- 2018-11-28
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Implandata Ophthalmic Products GmbH
- Target Recruit Count
- 24
- Registration Number
- NCT03756662
- Locations
- 🇩🇪
Universitäts-Augenklinik, Bochum, Germany
🇩🇪Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Augenklinik und Poliklinik, Mainz, Germany
🇩🇪Augenklinik der LMU München, München, Germany
Long-term Safety and Performance of the ARGOS-IO Intraocular Pressure Sensor System in Subjects With Primary Open Angle Glaucoma (POAG)
- Conditions
- Primary Open-angle Glaucoma
- First Posted Date
- 2018-08-29
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- Implandata Ophthalmic Products GmbH
- Target Recruit Count
- 16
- Registration Number
- NCT03651336
- Locations
- 🇩🇪
Klinik für Augenheilkunde, Uniklinik RWTH Aachen, Aachen, Germany
🇩🇪Universitäts-Augenklinik Bochum, Bochum, Germany
🇩🇪Universitätsaugenklinik Magdeburg, Magdeburg, Germany
Safety and Performance Study of the ARGOS-IO System in Patients Undergoing Boston Keratoprosthesis Implantation
- Conditions
- Stevens-Johnson SyndromeCongenital GlaucomaCongenital AniridiaGraft vs Host DiseaseChemical Burns
- First Posted Date
- 2016-10-26
- Last Posted Date
- 2025-02-27
- Lead Sponsor
- Implandata Ophthalmic Products GmbH
- Target Recruit Count
- 13
- Registration Number
- NCT02945176
- Locations
- 🇩🇪
Zentrum für Augenheilkunde der Universität zu Köln, Cologne, Germany
🇩🇪MVZ Prof. Neuhann, Munich, Germany
Safety and Performance Study of the ARGOS-IO (Intraocular) System in Patients With Primary Open Angle Glaucoma (POAG)
- Conditions
- Primary Open Angle Glaucoma (POAG)
- First Posted Date
- 2015-05-05
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- Implandata Ophthalmic Products GmbH
- Target Recruit Count
- 24
- Registration Number
- NCT02434692
- Locations
- 🇩🇪
Augenklinik Universitätsklinikum Aachen, Aachen, Germany
🇩🇪Augen-Zentrum-Nordwest, Ahaus, Germany
🇩🇪Universitäts-Augenklinik Bochum, Bochum, Germany